« Back
Home /
Radotinib

Radotinib

€42.00

Excl. VAT

Item no.	TMO-T2328-5mg
Manufacturer	TargetMol
CASRN	926037-48-1
Amount	5mg
Category	Oncology Reagents & Chemicals Molecules By Organ Heart & Blood Cancer
Type	Molecules
Specific against	other
Purity	0,98
Smiles	Cc1c(cc(cc1)C(=O)Nc1cc(cc(c1)n1cc(nc1)C)C(F)(F)F)Nc1nccc(n1)c1nccnc1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Radotinib, IY-5511; Supect, IY-5511 , Supect
Similar products	926037-48-1
Available
Short Description	Radotinib, and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors
Shipping	cool pack
Storage	-20°
Target names or alias	IY-5511 , Supect
Molecular Weight	530, 5
Pathway	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|Cytoskeletal Signaling
Target	Bcr-Abl

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

Listprice: €42.00

Price: €42.00

available

Delivery expected until 8/21/2025

Quantity:

Compare